News Article

Proposals for change from inside and outside the US FDA

US Food and Drug Administration (FDA) proposes structural changes within the institution in response to recent critique; includes increased focus on nutrition, partnerships with other regulatory authorities and incorporating outside advisors; Center for Science in the Public Interest (CSPI) publishes report on obesogens; encourages FDA to ‘incorporate framework’ to identify obesogens and other endocrine disruptors when reviewing chemical safety